文献速递脑血管病

共存血管疾病对TIA或卒中后长期复发事件风险的影响

Effect of coexisting vascular disease on long-term risk of recurrent events after TIA or stroke.
PubMed 文献 · Neurology · 2019-07-23

基于牛津郡人群研究(2002-2014年,2555例TIA/缺血性卒中患者),按现行二级预防指南治疗,共存心血管疾病患者10年冠脉事件风险(22.8% vs 7.1%)和复发性缺血性卒中风险(31.5% vs 23.4%)均更高,但非心源性栓塞患者颅外出血风险亦增高,尤其<75岁者。

要点

  • 共存心血管疾病的TIA/卒中患者10年冠脉事件风险显著增高(HR 3.07)。
  • 复发性缺血性卒中风险亦增高(HR 1.23,95%CI 0.99-1.53)。
  • 非心源性栓塞患者颅外出血风险增高(HR 2.71),尤其<75岁者。

核心结论

  • 尽管接受现行二级预防治疗,共存心血管疾病的TIA/卒中患者仍存在高复发性缺血事件风险。
  • 更强化降脂可能合理,但增加抗栓治疗的获益可能被更高的颅外出血风险抵消。

研究设计与样本

  • 基于牛津郡人群的队列研究(Oxford Vascular Study),纳入2002-2014年连续TIA或缺血性卒中患者。
  • 共2555例患者,9148患者年随访,按现行二级预防指南治疗。

主要发现

  • 640例(25.0%)存在共存心血管疾病(449例仅冠脉,103例仅外周,88例两者均有)。
  • 共存心血管疾病者10年冠脉事件风险22.8%(95%CI 17.4-27.9)vs 无共存者7.1%(5.3-8.8),p<0.001,年龄性别调整HR 3.07(2.24-4.21)。
  • 复发性缺血性卒中风险31.5%(25.1-37.4)vs 23.4%(20.5-26.2),p=0.0049,年龄性别调整HR 1.23(0.99-1.53)。
  • 非心源性栓塞患者颅外出血风险:<75岁者8.1%(2.8-13.0)vs 3.4%(1.6-5.3),p=0.0050,年龄性别调整HR 2.71(1.16-6.30)。
  • 颅内出血风险未增加(年龄性别调整HR 0.36,0.04-2.99)。

临床怎么用

  • 对共存心血管疾病的TIA/卒中患者应认识到其高复发缺血风险,考虑更强化降脂治疗。
  • 增加抗栓治疗前需权衡颅外出血风险,尤其<75岁非心源性栓塞患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether patients with TIA or ischemic stroke with coexisting cardiovascular disease (i.e., history of coronary or peripheral artery disease) are still at high risk of recurrent ischemic events despite current secondary prevention guidelines. METHODS: In a population-based study in Oxfordshire, UK (Oxford Vascular Study), we studied consecutive patients with TIA or ischemic stroke for 2002-2014. Patients were treated according to current secondary prevention guidelines and we determined risks of coronary events, recurrent ischemic stroke, and major bleeding stratified by the presence of coexisting cardiovascular disease. RESULTS: Among 2,555 patients (9,148 patient-years of follow-up), those (n = 640; 25.0%) with coexisting cardiovascular disease (449 coronary only; 103 peripheral only; 88 both) were at higher 10-year risk of coronary events than those without (22.8%, 95% confidence interval 17.4-27.9; vs 7.1%, 5.3-8.8; p < 0.001; age- and sex-adjusted hazard ratio [HR] 3.07, 2.24-4.21) and of recurrent ischemic stroke (31.5%, 25.1-37.4; vs 23.4%, 20.5-26.2; p = 0.0049; age- and sex-adjusted HR 1.23, 0.99-1.53), despite similar rates of use of antithrombotic and lipid-lowering medication. However, in patients with noncardioembolic TIA/stroke, risk of extracranial bleeds was also higher in those with coexisting cardiovascular disease, particularly in patients aged <75 years (8.1%, 2.8-13.0; vs 3.4%, 1.6-5.3; p = 0.0050; age- and sex-adjusted HR 2.71, 1.16-6.30), although risk of intracerebral hemorrhage was not increased (age- and sex-adjusted HR 0.36, 0.04-2.99). CONCLUSIONS: As in older studies, patients with TIA/stroke with coexisting cardiovascular disease remain at high risk of recurrent ischemic events despite current management. More intensive lipid-lowering might therefore be justified, but benefit from increased antithrombotic treatment might be offset by the higher risk of extracranial bleeding.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Boulanger M, Li L, Lyons S, et al. Effect of coexisting vascular disease on long-term risk of recurrent events after TIA or stroke. Neurology. 2019. PMID: 31337715. doi:10.1212/WNL.0000000000007935

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。